A Study to Investigate the Influence of MK0859 on Blood Pressure

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study will investigate the influence of MK0859 on ambulatory blood pressure, and how safe and tolerable MK0859 is on the subjects This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

See also
Status	Clinical Trial	Phase
Completed	`NCT03855605` - Diagnosis of Hypertension by Home Blood Pressure Monitoring
Recruiting	`NCT01522430` - Study of Catheter Based Renal Denervation Therapy in Hypertension	Phase 3
Recruiting	`NCT05167240` - ESH ABPM COVID-19 STUDY
Active, not recruiting	`NCT03868384` - The Effect of Home Blood Pressure Measurement on the Management of Hypertension

NCT number	NCT00565006
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 1
Start date	July 2006
Completion date	September 2006

A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms